Skip to main content

Table 4 Use of drugs, medical aids and remedies of prevalent HD patients in 2015 and 2016

From: Epidemiology and health care utilization of patients suffering from Huntington’s disease in Germany: real world evidence based on German claims data

 

Women (n = 139)

Men (n = 169)

All (n = 308)

n

%

Mean costs per patient and year

Mean DDD per year

n

%

Mean costs per patient and year

Mean DDD per year

n

%

Mean costs per patient and year

Mean DDD per year

Drugs

 Anticonvulsants

21

15.1%

153.76 €

132.9

30

17.8%

146.93 €

124.7

51

16.6%

149.74 €

128.1

 Antidepressants

62

44.6%

129.50 €

356.4

77

45.6%

121.78 €

349.1

139

45.1%

125.22 €

352.3

 Antipsychotics

91

65.5%

633.34 €

467.6

115

68.0%

495.95 €

322.2

206

66.9%

556.64 €

386.5

 Hypnotics

15

10.8%

67.54 €

86.6

15

8.9%

43.22 €

84.0

30

9.7%

55.38 €

85.3

 Opioids

20

14.4%

214.81 €

47.6

25

14.8%

90.98 €

33.7

45

14.6%

146.02 €

39.9

Medical aids

 Nursinga

40

28.8%

46

27.2%

86

27.9%

 Physical therapy

65

46.8%

795.43 €

78

46.2%

791.01 €

143

46.4%

793.02 €

 Psychotherapy

/

/

/

< 5

/

/

10

3.2%

553.39 €

 Speech therapy

28

20.1%

1232.98 €

42

24.9%

966.42 €

70

22.7%

1073.04 €

Remedies

 Walking aid

14

10.1%

128.33 €

15

8.9%

61.28 €

29

9.4%

93.65 €

 Wheelchair use

27

19.4%

481.91 €

29

17.2%

591.71 €

56

18.2%

538.77 €

  1. Numbers which are too low or might allow indirect calculability of too low case numbers cannot be displayed due to data protection reasons
  2. aCosts for nursing services were not comprised by the database